2-Amino-3-(4-(tert-butyl)phenyl)propanoic acid
95%
- Product Code: 42575
CAS:
98708-80-6
| Molecular Weight: | 221.2955 g./mol | Molecular Formula: | C₁₃H₁₉NO₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD05227971 | |
| Melting Point: | Boiling Point: | 347.5 °C at 760 mmHg | |
| Density: | 1.084 g/cm3 | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological disorders. Its structure, featuring a tert-butylphenyl group, makes it valuable in the development of compounds with potential applications in treating conditions like depression, anxiety, and neurodegenerative diseases. Additionally, it is explored in the design of peptide-based drugs due to its amino acid backbone, which can enhance binding affinity and stability. Researchers also investigate its use in creating novel inhibitors for enzymes involved in metabolic pathways, contributing to the development of therapeutic agents for metabolic diseases.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $62.13 |
+
-
|
2-Amino-3-(4-(tert-butyl)phenyl)propanoic acid
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological disorders. Its structure, featuring a tert-butylphenyl group, makes it valuable in the development of compounds with potential applications in treating conditions like depression, anxiety, and neurodegenerative diseases. Additionally, it is explored in the design of peptide-based drugs due to its amino acid backbone, which can enhance binding affinity and stability. Researchers also investigate its use in creating novel inhibitors for enzymes involved in metabolic pathways, contributing to the development of therapeutic agents for metabolic diseases.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :